
Sign up to save your podcasts
Or
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.7
453453 ratings
On Monday, the FTC told Illumina to dissolve their acquisition with the multi-cancer early detection test company Grail. David Lim talks with host Ben Leonard about what this move means for the development and commercialization of cancer tests in the United States.
Learn more about your ad choices. Visit megaphone.fm/adchoices
5,071 Listeners
4,199 Listeners
3,170 Listeners
609 Listeners
25,770 Listeners
1,511 Listeners
668 Listeners
110,824 Listeners
964 Listeners
308 Listeners
55,990 Listeners
102 Listeners
206 Listeners
11,735 Listeners
138 Listeners
390 Listeners
388 Listeners
39 Listeners
696 Listeners
1,180 Listeners
11 Listeners